Loading...
Powered By
19 items
2025-04-01
The company closed its plan on April 1, 2025.
2025-04-01
From March 31, 2025 to April 1, 2025, the company has repurchased 848,100 shares, representing 4.41% for ¥1,195.82 million. With this, the company has completed the repurchase of 848,100 shares, representing 4.41% for ¥1,195.82 million under the buyback announced on March 31, 2025.
2025-03-31
B-Lot Company Limited (TSE:3452) announces a share repurchase program. Under the program, the company will repurchase up to 848,100 shares, representing 4.44% of its issued share capital, for ¥1,195.821 million. The shares will be repurchased at a price of ¥1,410 per share. The program aims to secure stable management rights and facilitate capital partnerships. As of March 31, 2025, the company had 19,120,638 outstanding shares(excluding treasury shares) and 911,762 treasury shares.
2025-03-31
The Board of Directors of B-Lot Company Limited has authorized a buyback plan on March 31, 2025.
2025-03-12
From January 1, 2025 to March 11, 2025, the company has repurchased 148,300 shares, representing 0.77% for ¥173.11 million. With this, the company has completed the repurchase of 434,600 shares, representing 2.25% for ¥499.89 million under the buyback announced on September 30, 2024.
2025-03-12
The company closed its plan on March 11, 2025.
2025-03-01
B-Lot Company Limited announced that they will report Q1, 2025 results on May 15, 2025
2025-02-14
B-Lot Company Limited, Annual General Meeting, Mar 28, 2025.
2025-01-20
B-Lot Company Limited (TSE:3452) agreed to acquire Kumasyu Co., Ltd. from Hidefumi Kumaoka for ¥8.8 billion on November 14, 2024. A cash consideration of ¥8.77 billion will be paid by B-Lot Company Limited. As part of consideration, ¥8.77 billion is paid towards common equity of Kumasyu Co., Ltd. For the period ending February 29, 2024, Kumasyu Co., Ltd. reported total revenue of ¥13.44 billion, EBIT of ¥2.34 billion and net income of ¥1.23 billion. As of February 29, 2024, Kumasyu Co., Ltd. reported total assets of ¥33.48 billion and total common equity of ¥8.5 billion. The expected completion of the transaction is January 17, 2025. B-Lot Company Limited (TSE:3452) completed the acquisition of Kumasyu Co., Ltd. from Hidefumi Kumaoka on January 17, 2025. On completion, Kumasyu will become a consolidated subsidiary and will be included in our consolidated financial results from the second quarter of the fiscal year ending December 2025. The transaction is expected to include Kumasyu's profit and loss for the seven months from March 1, 2025 to September 30, 2025.
2025-01-06
From September 30, 2024 to December 31, 2024, the company has repurchased 286,300 shares, representing 1.48% for ¥326.78 million. With this, the company has completed the repurchase of 286,300 shares, representing 1.48% for ¥326.78 million under the buyback announced on September 30, 2024.
2025-01-03
B-Lot Company Limited announced that they will report fiscal year 2024 results on Feb 14, 2025
2024-12-11
Healthcare & Medical Investment Corporation (TSE:3455) agreed to acquire Trust beneficiary interests in Tsukui Sunshine Yokohama Totsuka, Yu-49 from B-Lot Company Limited (TSE:3452) for ¥1.15 billion on December 10, 2024. A cash consideration of ¥1.15 billion will be paid by Healthcare & Medical Investment Corporation. As part of consideration, ¥1.15 billion is paid towards assets of Trust beneficiary interests in Tsukui Sunshine Yokohama Totsuka, Yu-49. The acquisition will be funded via borrowings and cash in hand. The expected completion of the transaction is December 20, 2024.
2024-12-04
B-Lot Company Limited, ¥ 61.0, Cash Dividend, Dec-27-2024
2024-11-15
B-Lot Company Limited (TSE:3452) agreed to acquire Kumasyu Co., Ltd. from Hidefumi Kumaoka for ¥8.8 billion on November 14, 2024. A cash consideration of ¥8.77 billion will be paid by B-Lot Company Limited. As part of consideration, ¥8.77 billion is paid towards common equity of Kumasyu Co., Ltd. For the period ending February 29, 2024, Kumasyu Co., Ltd. reported total revenue of ¥13.44 billion, EBIT of ¥2.34 billion and net income of ¥1.23 billion. As of February 29, 2024, Kumasyu Co., Ltd. reported total assets of ¥33.48 billion and total common equity of ¥8.5 billion. The expected completion of the transaction is January 17, 2025.
2024-11-14
B-Lot Company Limited expected to report Fiscal Year 2024 results on February 14, 2025. This event was calculated by S&P Global (Created on November 14, 2024).
2024-10-07
The Board of Directors of B-Lot Company Limited has authorized a buyback plan on September 30, 2024.
2024-08-28
B-Lot Company Limited announced that they will report Q3, 2024 results on Nov 14, 2024
2024-08-14
B-Lot Company Limited expected to report Q3 2024 results on November 14, 2024. This event was calculated by S&P Global (Created on August 14, 2024).
2024-07-31
B-Lot Company Limited, Q2 2024 Earnings Call, Aug 22, 2024
2025Q1 | 2024Q4 | 2024Q3 | 2024Q2 | 2024Q1 | 2023Q4 | 2023Q3 | |
|---|---|---|---|---|---|---|---|
Total Revenues | 33,225 | 30,933 | 31,766 | 25,908 | 19,859 | 23,510 | 27,020 |
Pretax Income Excl.Unusual Items | 6,285 | 5,811 | 7,344 | 5,630 | 4,572 | 4,943 | 4,996 |
Total Assets | 93,601 | 56,900 | 55,628 | 57,873 | 59,504 | 57,240 | 51,300 |
Total Liabilities | 76,462 | 39,231 | 37,202 | 41,256 | 44,846 | 42,202 | 37,192 |
Cash & Cash Equivalents | 11,317 | 12,273 | 16,500 | 12,555 | 8,621 | 10,367 | 9,803 |
Total Common Equity | 17,129 | 17,658 | 18,415 | 16,295 | 14,336 | 14,715 | 14,076 |
Book Value Per Share (BVPS) | 892.1 | 917.69 | 948.83 | 841.32 | 749.03 | 768.83 | 733.06 |
Net Change in Cash | 1,903 | 3,554 | 421 | ||||
Capital Expenditure | -334 | -101 | -123 |
B-Lot revealed its financial results for the first quarter of 2025 on May 15, 2025, having revenues of 5.54B yen and net income of 818M yen, reflecting a significant 70.6% surge in revenue, along with a significant increase of approximately 41% in EPS compared with the same quarter last year.
In addition, the EBITDA margin moderate decline from 30.5% in the corresponding quarter last year to 27.8%. and it trades at 6.4x times current year's earnings, which is lower than the sector average (P/E 10.4x).